Clinical RoundupFree USC Study shows inherited risk of early-onset cancer is higher among Latino, African American, and Asian/Pacific Islander families June 25, 2021Vol.47 No.25
Clinical RoundupFree UCI-led study finds that cancer immunotherapy may self-limit its efficacy June 25, 2021Vol.47 No.25
Clinical RoundupFree Study: combination treatment effective in IDH mutant cancers June 25, 2021Vol.47 No.25
Clinical RoundupFree Immunotherapy drug combination improves response in HER2-negative breast cancer, including a subset of estrogen receptor positive cancers June 25, 2021Vol.47 No.25
Clinical RoundupFree Yale Cancer Center study reveals new pathway for brain tumor therapy June 25, 2021Vol.47 No.25
Drugs & TargetsFree Libtayo approved by European Commission for first-line treatment of patients with advanced NSCLC with ≥50% PD-L1 expression June 25, 2021Vol.47 No.25
Drugs & TargetsFree Abecma receives positive CHMP opinion for relapsed and refractory multiple myeloma June 25, 2021Vol.47 No.25
Drugs & TargetsFree Opdivo receives positive CHMP opinion as adjuvant treatment for GEJ cancer patients with residual pathologic disease following chemoradiotherapy June 25, 2021Vol.47 No.25
Drugs & TargetsFree European Commission approves Onureg for certain AML subtypes June 25, 2021Vol.47 No.25
FreeIn the Archives On the shoulders of giants: Research milestones and the Rabson-Kirschstein photo archive June 18, 2021Vol.47 No.24
